gMendel® is a medical innovation startup in Denmark that aims to transform the diagnosis of genetic disorders for better disease management. Our approach is powered by genomics, AI and blockchain technology, and our mission is to provide a shorter, safer and economical path to accurate diagnosis of genetic disorders and potential treatment. Why: Accurate diagnosis remains a long and painful process that takes 7 years. Even with dozens of medical examinations, 40% of patients are still misdiagnosed. This creates a challenge for patients, doctors and healthcare systems, and the lifetime cost can reach €2.5M per patient. The current clinical protocol relies on a set of non accurate conventional techniques as advanced genomic technologies have high cost and complexity. What: gMendel® technology combines Genomics, AI/Machine Learning & Blockchain, and provides a shorter, safer and more economical path to accurate diagnosis. At the same time, we ensure the highest security & patient data encryption. Our method relies on multilevel multiplexing, DNA sequencing and demultiplexing of barcodes through which genetic disorder classification and detection of a large number of samples is performed by following a deep learning multi model fusion strategy. How: Partnerships with hospitals, research institutes and advocacy groups give access to KOLs & samples, we validate the accuracy, specificity & sensitivity of our proprietary method, while accelerating our AI algorithm development by using state-of-the-art ML methods, combined with deep clinical understanding. Who: We have an extraordinary team of research scientists, engineers with domain expertise from working closely with doctors, biomedical research, and genetic outputs - combined with colleagues with experience/expertise from other institutes, funding and commercialization within the health-tech industry.